PHENYLALANINE

PHENYLALANINE was reported 399 times

These side effects are most commonly reported by patients taking PHENYLALANINE:

# Side effect Count
0 CONDITION AGGRAVATED 18
1 BRADYCARDIA 12
2 CARDIAC ARREST 12
3 CARDIOGENIC SHOCK 12
4 COMA SCALE ABNORMAL 12
5 COMPARTMENT SYNDROME 12
6 HYPERKALAEMIA 12
7 HYPOTENSION 12
8 ILEUS 12
9 LACTIC ACIDOSIS 12
10 OVERDOSE 12
11 PULSE ABSENT 12
12 RHABDOMYOLYSIS 12
13 VASOPLEGIA SYNDROME 12
14 OFF LABEL USE 10
15 FATIGUE 9
16 DIZZINESS 8
17 MEMORY IMPAIRMENT 8
18 ANXIETY 6
19 DIARRHOEA 6
20 ACINETOBACTER INFECTION 5
21 DECREASED APPETITE 5
22 MALNUTRITION 5
23 NAUSEA 5
24 ABDOMINAL DISCOMFORT 4
25 DISEASE PROGRESSION 4
26 FALL 4
27 FEELING ABNORMAL 4
28 HEADACHE 4
29 LIGAMENT SPRAIN 4
30 THERAPEUTIC RESPONSE UNEXPECTED 4
31 COGNITIVE DISORDER 3
32 DRUG HYPERSENSITIVITY 3
33 DRUG INEFFECTIVE 3
34 FACE INJURY 3
35 HEPATIC FAILURE 3
36 INSOMNIA 3
37 INTENTIONAL PRODUCT USE ISSUE 3
38 LOSS OF CONSCIOUSNESS 3
39 MALAISE 3
40 OROPHARYNGEAL PAIN 3
41 PARAESTHESIA 3
42 POST-TRAUMATIC STRESS DISORDER 3
43 RASH 3
44 VOMITING 3
45 WRIST FRACTURE 3
46 ABDOMINAL DISTENSION 2
47 ARTHRALGIA 2
48 BACK PAIN 2
49 BURNING SENSATION 2
50 CONFUSIONAL STATE 2
51 CONSTIPATION 2
52 COUGH 2
53 DEPRESSION 2
54 DISTURBANCE IN ATTENTION 2
55 DRUG INTERACTION 2
56 DRUG INTOLERANCE 2
57 FLATULENCE 2
58 FOOD ALLERGY 2
59 FOOD CRAVING 2
60 GASTROINTESTINAL DISORDER 2
61 ILLNESS ANXIETY DISORDER 2
62 INFECTION 2
63 MAST CELL ACTIVATION SYNDROME 2
64 MENTAL DISORDER 2
65 MONONEUROPATHY 2
66 MUSCLE SPASMS 2
67 PERIPHERAL SWELLING 2
68 PRE-EXISTING CONDITION IMPROVED 2
69 PYREXIA 2
70 RESPIRATORY DISORDER 2
71 RESTLESS LEGS SYNDROME 2
72 SALIVARY HYPERSECRETION 2
73 SOMNOLENCE 2
74 THIRST 2
75 WEIGHT DECREASED 2
76 WEIGHT INCREASED 2
77 WITHDRAWAL SYNDROME 2
78 ABDOMINAL PAIN UPPER 1
79 ABNORMAL DREAMS 1
80 AFFECT LABILITY 1
81 ALLERGIC SINUSITIS 1
82 ALOPECIA 1
83 AMINO ACID LEVEL DECREASED 1
84 AMNESIA 1
85 AMNIOTIC CAVITY INFECTION 1
86 ANAEMIA 1
87 ANAPHYLACTIC REACTION 1
88 APPLICATION SITE DRYNESS 1
89 APPLICATION SITE ERYTHEMA 1
90 APPLICATION SITE PRURITUS 1
91 APPLICATION SITE URTICARIA 1
92 ARTHRITIS 1
93 ARTIFICIAL MENOPAUSE 1
94 ASTHENIA 1
95 BARRETT'S OESOPHAGUS 1
96 BLIGHTED OVUM 1
97 BLINDNESS TRANSIENT 1
98 BLOOD GLUCOSE INCREASED 1
99 BLOOD PRESSURE INCREASED 1
100 BLOOD SODIUM DECREASED 1
101 BLOOD THYROID STIMULATING HORMONE DECREASED 1
102 BLOOD TRIGLYCERIDES INCREASED 1
103 BREAST TENDERNESS 1
104 BURSITIS 1
105 C-REACTIVE PROTEIN INCREASED 1
106 CALCINOSIS 1
107 CELLULITIS 1
108 CHEST DISCOMFORT 1
109 CHROMATURIA 1
110 CLOSTRIDIUM DIFFICILE INFECTION 1
111 COELIAC DISEASE 1
112 COMA 1
113 CONJUNCTIVITIS 1
114 CONTUSION 1
115 COVID-19 1
116 CROHN^S DISEASE 1
117 CYSTITIS HAEMORRHAGIC 1
118 DEATH 1
119 DEPRESSED MOOD 1
120 DRUG EFFECT DECREASED 1
121 DRUG EXPOSURE DURING PREGNANCY 1
122 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
123 DRUG PRESCRIBING ERROR 1
124 DRUG-INDUCED LIVER INJURY 1
125 DRY MOUTH 1
126 DYSURIA 1
127 EAR CONGESTION 1
128 EMOTIONAL DISTRESS 1
129 ENDOCRINE DISORDER 1
130 ENDOTRACHEAL INTUBATION 1
131 ENGRAFTMENT SYNDROME 1
132 EPILEPSY 1
133 EXFOLIATIVE RASH 1
134 EYELID DISORDER 1
135 FEELING COLD 1
136 FIBROMYALGIA 1
137 FIBULA FRACTURE 1
138 FOETAL EXPOSURE DURING PREGNANCY 1
139 FOOT FRACTURE 1
140 FREQUENT BOWEL MOVEMENTS 1
141 GAIT DISTURBANCE 1
142 GASTROOESOPHAGEAL REFLUX DISEASE 1
143 HAEMOPTYSIS 1
144 HAEMORRHAGE 1
145 HAEMORRHOIDS 1
146 HALLUCINATION 1
147 HALLUCINATION, AUDITORY 1
148 HALLUCINATION, TACTILE 1
149 HALLUCINATION, VISUAL 1
150 HEMIPARESIS 1
151 HEPATIC CIRRHOSIS 1
152 HEPATIC ENCEPHALOPATHY 1
153 HEPATIC NECROSIS 1
154 HEPATOTOXICITY 1
155 HIGH DENSITY LIPOPROTEIN DECREASED 1
156 HYPERTENSION 1
157 HYPOCALCAEMIA 1
158 HYPOKALAEMIA 1
159 HYPOKINESIA 1
160 HYPONATRAEMIA 1
161 HYPOPHAGIA 1
162 HYPOTHYROIDISM 1
163 HYSTERECTOMY 1
164 IDIOPATHIC URTICARIA 1
165 IMPAIRED QUALITY OF LIFE 1
166 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
167 INFLAMMATION 1
168 INFUSION SITE DISCHARGE 1
169 INFUSION SITE ERYTHEMA 1
170 INFUSION SITE HAEMORRHAGE 1
171 INFUSION SITE PRURITUS 1
172 INFUSION SITE RASH 1
173 INFUSION SITE URTICARIA 1
174 INTERSTITIAL LUNG DISEASE 1
175 JC VIRUS INFECTION 1
176 JOINT INJURY 1
177 JOINT SWELLING 1
178 LIGAMENTITIS 1
179 LIMB MASS 1
180 LOW DENSITY LIPOPROTEIN INCREASED 1
181 MATERNAL EXPOSURE DURING PREGNANCY 1
182 MECHANICAL VENTILATION 1
183 MEIBOMIAN GLAND DYSFUNCTION 1
184 MULTIPLE SCLEROSIS RELAPSE 1
185 MUSCLE SPASTICITY 1
186 MUSCULOSKELETAL STIFFNESS 1
187 MYALGIA 1
188 NASOPHARYNGITIS 1
189 NEOPLASM PROGRESSION 1
190 NERVE INJURY 1
191 NEUROPATHY PERIPHERAL 1
192 NEUTROPHIL COUNT DECREASED 1
193 OEDEMA PERIPHERAL 1
194 OSTEOPOROSIS 1
195 PAIN 1
196 PAIN IN EXTREMITY 1
197 PARAESTHESIA ORAL 1
198 PENILE PAIN 1
199 PERIODIC LIMB MOVEMENT DISORDER 1
200 PERIPHERAL VEIN THROMBOSIS 1
201 PHLEBITIS 1
202 PLATELET COUNT DECREASED 1
203 PNEUMONIA 1
204 POLYCYSTIC OVARIAN SYNDROME 1
205 POST PROCEDURAL COMPLICATION 1
206 PREGNANCY 1
207 PREMATURE DELIVERY 1
208 PROCTALGIA 1
209 PRODUCT ADMINISTRATION ERROR 1
210 PRODUCT DOSE OMISSION ISSUE 1
211 PRODUCT USE ISSUE 1
212 PRODUCTIVE COUGH 1
213 PRURITUS 1
214 PULMONARY THROMBOSIS 1
215 RASH ERYTHEMATOUS 1
216 RASH MACULAR 1
217 RASH PAPULAR 1
218 RASH PRURITIC 1
219 RAYNAUD^S PHENOMENON 1
220 RESPIRATORY FAILURE 1
221 ROAD TRAFFIC ACCIDENT 1
222 SEASONAL ALLERGY 1
223 SENSITIVITY OF TEETH 1
224 SHOULDER OPERATION 1
225 SINUSITIS 1
226 SKIN EXFOLIATION 1
227 SLEEP APNOEA SYNDROME 1
228 SLEEP DISORDER 1
229 SLEEP PARALYSIS 1
230 SOCIAL PROBLEM 1
231 SPINAL FUSION SURGERY 1
232 SPINAL LAMINECTOMY 1
233 STENOSIS 1
234 STILLBIRTH 1
235 STRESS 1
236 SUDDEN ONSET OF SLEEP 1
237 SURGERY 1
238 SWELLING 1
239 SYNCOPE 1
240 TOOTH EXTRACTION 1
241 TRANSIENT ISCHAEMIC ATTACK 1
242 TREMOR 1
243 TRI-IODOTHYRONINE INCREASED 1
244 TRICHORRHEXIS 1
245 UPPER RESPIRATORY TRACT INFECTION 1
246 URINE ABNORMALITY 1
247 URINE ODOUR ABNORMAL 1
248 VARICOSE VEIN 1
249 VISION BLURRED 1
250 WHITE BLOOD CELL COUNT DECREASED 1
251 WISDOM TEETH REMOVAL 1
252 WOUND SECRETION 1
253 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1